BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) announced that the underwriters of its recent public offering of its common stock have exercised ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE